Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0028754 (
obesity
)
124,988
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The aim of the current study was to analyze the effect of six type II diabetes GWAS loci rs3923113 (GRB14), rs16861329 (ST6GAL1), rs1802295 (VPS26A), rs7178572 (HMG20A), rs2028299 (
AP3S2
) and rs4812829 (HNF4A), and an FTO polymorphism (rs9939609) on
obesity
. The probable mechanism of action of these SNPs was analyzed by studying their association with various biochemical and anthropometric parameters. A total of 475 subjects (obese=250, controls=225) were genotyped by TaqMan assay and their lipid profile was determined. Allele/genotype frequencies and an unweighted/weighted gene score were calculated. The effect of the gene score on anthropometric and biochemical parameters was analyzed. The minor allele frequencies of all variants were comparable to that reported in the original studies and were associated with
obesity
in these Pakistani subjects. Subjects with 9 risk alleles differ from those with <3 and overall there is no significant effect (P-value for trend 0.26). None of the SNPs were associated with any of the serum lipid traits. We are the first to report the association of these T2D SNPs with
obesity
. In the Pakistani population the reported effect of six SNPs for
obesity
is similar to that reported for T2D and having a combination of risk alleles on
obesity
can be considerable. The mechanism of this effect is unclear, but appears not to be mediated by changing serum lipid chemistry.
...
PMID:Effect of six type II diabetes susceptibility loci and an FTO variant on obesity in Pakistani subjects. 2639 51
The mechanisms that underlie the association between
obesity
and type 2 diabetes are not fully understood. Here, we investigated the role of the 3D genome organization in the pathogeneses of
obesity
and type-2 diabetes. We interpreted the combined and differential impacts of 196 diabetes and 390
obesity
associated single nucleotide polymorphisms (SNPs) by integrating data on the genes with which they physically interact (as captured by Hi-C) and the functional [i.e., expression quantitative trait loci (eQTL)] outcomes associated with these interactions. We identified 861 spatially regulated genes (e.g.,
AP3S2
, ELP5, SVIP, IRS1, FADS2, WFS1, RBM6, HORMAD1, PYROXD2
), which are enriched in tissues (e.g., adipose, skeletal muscle, pancreas) and biological processes and canonical pathways (e.g., lipid metabolism, leptin, and glucose-insulin signaling pathways) that are important for the pathogenesis of type 2 diabetes and
obesity
. Our discovery-based approach also identifies enrichment for eQTL SNP-gene interactions in tissues that are not classically associated with diabetes or
obesity
. We propose that the combinatorial action of active
obesity
and diabetes spatial eQTL SNPs on their gene pairs within different tissues reduces the ability of these tissues to contribute to the maintenance of a healthy energy metabolism.
...
PMID:Physical Interactions and Expression Quantitative Traits Loci Identify Regulatory Connections for Obesity and Type 2 Diabetes Associated SNPs. 2908 91